January 10, 2017 — Teleflex Inc. announced that its Arrow VPS Rhythm Device with optional TipTracker technology has been issued U.S. Food and Drug Administration (FDA) 510(k) clearance to commercialize the device in the United States.
The Arrow VPS Rhythm Device assists in placement and confirmation of a catheter tip in the superior vena-cava-cavoatrial junction (SVC-CAJ); it may be used with a broad range of catheter types and brands. Intravascular P-wave changes are saved as the catheter approaches the SVC, helping to identify the lower third of the SVC, near the CAJ, eliminating the need for confirmatory chest X-ray or fluoroscopy in adult patients. When paired with the single-use TipTracker Stylet for insertion of peripherally-inserted central catheters (PICCs), the Arrow VPS Rhythm Device provides real-time visual navigation by tracing the catheter pathway with a blue line on a color screen. The device has an expansive sphere of visual navigation to provide easy navigation of the PICC during insertion.
For more information: www.teleflex.com